Syncona’s (SYNC) “Buy” Rating Reaffirmed at Peel Hunt

Syncona (LON:SYNC)‘s stock had its “buy” rating reiterated by equities research analysts at Peel Hunt in a report issued on Monday, October 12th, Digital Look reports. They currently have a GBX 189 price objective on the stock. Peel Hunt’s price target points to a potential upside of 46.97% from the stock’s previous close.

Syncona Stock Performance

Shares of LON:SYNC traded down GBX 0.40 during midday trading on Monday, reaching GBX 128.60. 369,216 shares of the company’s stock were exchanged, compared to its average volume of 897,390. The company’s 50 day simple moving average is GBX 115.45 and its two-hundred day simple moving average is GBX 104.15. The firm has a market capitalization of £782.15 million, a PE ratio of -88.69 and a beta of 0.36. Syncona has a 12 month low of GBX 86.80 and a 12 month high of GBX 131.80.

Syncona Company Profile

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.